The microtubule-associated protein (MAP) tau, which is abnormally hyperphosphorylated in the brain of patients with Alzheimer disease, sequesters normal MAPs and disassembles microtubules. The association between the abnormal tau and normal tau, and not MAP1 or MAP2, produces tangles of filaments. The breakdown of microtubule network most likely results in compromised axonal transport and retrograde degeneration of the affected neurons.
Alzheimer disease (AD) has polyetiology. Over 90% of Neurons with neurofibrillary tangles lack microtubules, and microtubules assembly from AD brain cytothe AD cases have the sporadic form of the disease the cause of which could be, as yet to be identified, sol is not observed. 9 PHF are comprised mainly of the microtubule-associated protein (MAP) tau in an abnorenvironmental and or metabolic factors. Of the remaining less than 10% of the AD cases which are familial, mally hyperphosphorylated state. [10] [11] [12] In addition to PHF there is a pool of cytosolic abnormally phosabout one half of them are due to mutations in presenilin-1, presenilin-2 or ␤-amyloid precursor protein phorylated tau in the affected neurons. 9, 13 This pool of the abnormal tau seen immunocytochemically as the genes. Independent of the etiology, ie, whether genetic or non-genetic, AD is characterized by a specific type 'stage 0' tangles 14 is most likely the precursor to PHF since the neurofibrillary tangles have very little turnof neuronal degeneration, called neurofibrillary degeneration. The neuronal cytoskeleton in AD is proover, if any, and survive even after the death of the affected neurons as the 'ghost' tangles. gressively disrupted and displaced by the appearance of bundles of paired helical filaments (PHF), the neuroTau promotes the assembly of tubulin into microtubules and maintains the structure of microtubules. fibrillary tangles. In addition to the neuronal perikaryon, the PHF also accumulate in the neuropil as neuroMicrotubules in turn are required for the axonal transport. These functions of tau are regulated by its degree pil threads and as dystrophic neurites surrounding wisps or a core of ␤-amyloid in the neuritic plaques. To of phosphorylation. The normal brain tau, which is optimally active, has 2-3 moles of phosphates per mole date, the exact relationship between the neurofibrillary degeneration and the ␤-amyloidosis, the two hallmark of the protein. Tau in PHF and in AD brain, which is abnormally hyperphosphorylated, contains 5-9 moles lesions of AD, is not understood. The bulk of the data suggests that these two lesions can be formed indepenof phosphate per mole of the protein. 13 Unlike normal tau, the AD abnormally hyperphosphorylated tau (AD dently of each other and that neither might be the cause of the formation of the other in AD. The number of P-tau) does not promote the in vitro assembly of microtubles, bind to microtubules or stabilize their neurons undergoing neurofibrillary degeneration increases with the progression of the disease and correstructure. 5, 15, 16 The AD P-tau competes with tubulin in binding to normal tau, inhibits the assembly of lates with the degree of dementia.
1-4 ␤-amyloidosis alone, in the absence of neurofibrillary degeneration microtubules and the association of AD P-tau with normal tau results in tangles of ෂ3.3-nm straight filaments. does not produce the disease clinically. Thus understanding the molecular mechanism of the neurofibrilUnlike normal tau, the abnormally phosphorylated tau in AD brain is glycosylated and deglycosylation of AD lary degeneration is critical to devising a rational therapeutic treatment of all forms of AD. We have now neurofibrillary tangles by endoglycosidase F/N glycosidase F converts them into tangles of thin straight filafound how the microtubule-associated protein tau which is abnormally hyperphosphorylated in the brain ments 7 similar to those formed by the association of the AD P-tau and the normal tau. 5 of AD patients could be causing the degeneration of the affected neurons and forming the neurofibrillary In addition to tau, the neuron contains MAP1 and MAP2 which also promote microtubule assembly and tangles. In the latest study we investigated whether in the presence of the abnormicrotubules. 5-8 Thus, one of the most promising therapeutic targets for both sporadic as well as the fammally hyperphosphorylated tau, the HMW-MAPs can maintain the structure of microtubules. We have found:
ilial form of AD is to prevent neurofibrillary degeneration by inhibiting the abnormal hyperphosphorylation (i) that the high molecular weight MAP1 and MAP2 associate to AD P-tau; (ii) that the affinity of the bindof tau (see Image Section). ing between the AD P-tau and normal tau is higher than K Iqbal and I Grundke-Iqbal that between AD P-tau and the HMW-MAPs; and New York State Institute for Basic Research in Devel-(iii) that the AD P-tau sequesters the HMW-MAPs from opmental Disabilities microtubules resulting in the disassembly of microtu-1050 Forest Hill Road, Staten Island bules. However, unlike the association between the AD New York 10314, USA P-tau and the normal tau, the binding of AD P-tau to MAP1 or MAP2 does not result in the formation of tangles or individual long filaments.
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The association between the AD P-tau and the HMW- and restores its ability to promote the assembly of
